TIR10Tirzepatide
Dual GLP-1 / GIP agonist · metabolic & weight research
Tirzepatide (Mounjaro®) is a dual GIP and GLP-1 receptor agonist. Phase 3 SURMOUNT trials demonstrated industry-leading weight loss outcomes alongside significant metabolic improvements.
For research use only. Not for human consumption.
Pricingchoose unit at checkout
Vial
Single vial
€39.90
Kit
Multi-vial pack
€187.50
For laboratory research use only. Not for human or veterinary consumption.
COA / lab tests
View all →- Tirzepatide 60 mg — ERP batchJanoshik
- Tirzepatide 30 mg — ERP batchJanoshik
- Tirzepatide 15 mg — ERP batchJanoshik
Order
Unit
Quantity (vials)
Subtotal€39.90
Choose vial or kit above. For laboratory research use only.
